Business ❯ Healthcare ❯ Medical Devices

Robotic Surgery

Intuitive Surgical da Vinci System Market Competition Clinical Studies

Investors Weigh Intuitive Surgical’s Growth Against Medtronic’s Value in Robotic Surgery

The choice turns on appetite for valuation risk versus income-focused exposure to surgical robotics.

Medtronic Tops Q2 Estimates, Lifts Outlook on Cardiovascular and Diabetes Strength

Intuitive Surgical Set to Report Q3 Results Oct. 16 With Wall Street Expecting $1.59 EPS